• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎患者门静脉血栓形成:系统评价。

Portal vein thrombosis in patients with COVID-19: A systematic review.

机构信息

Department of Surgery, Faculty of Medicine, Jouf University, Saudi Arabia; Department of Surgery, Faculty of Medicine for Girls, Al-Azhar University, Egypt.

Department of Surgery, Faculty of Medicine for Girls, Al-Azhar University, Egypt.

出版信息

Asian J Surg. 2023 Aug;46(8):3017-3026. doi: 10.1016/j.asjsur.2022.11.002. Epub 2022 Nov 11.

DOI:10.1016/j.asjsur.2022.11.002
PMID:36435627
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9650574/
Abstract

Several studies have proven that COVID-19 is linked to a higher incidence of different thrombotic events. Thrombosis of the portal vein can result in portal hypertension and can extend to the mesenteric vein resulting in intestinal ischemia. A search of PubMed, Web of Science, and Scopus for relevant studies revealed an association between PVT and COVID-19. This review is structured according to PRISMA guidelines. Thirty-three studies met the inclusion criteria. Twenty-nine case studies/series and four cohort/cross-sectional studies were included. Age at diagnosis was lower when compared to PVT due to cirrhosis. In cohort/cross-sectional studies, males comprised 54.83% of subjects, whereas in case reports/series, males comprised 62.1%. Obesity, asthma, hypertension, and diabetes were the most common comorbidities identified. The majority of the thrombotic events occurred within two weeks. The treatment aimed to prevent thrombus progression and improve recanalization. According to the evidence, early intervention prevents the poor prognosis of intestinal ischemia and its propagation.

摘要

多项研究证实,COVID-19 与不同血栓事件的发生率增加有关。门静脉血栓形成可导致门静脉高压,并延伸至肠系膜静脉导致肠缺血。在 PubMed、Web of Science 和 Scopus 中搜索相关研究,发现 PVT 与 COVID-19 之间存在关联。本综述根据 PRISMA 指南进行构建。符合纳入标准的研究有 33 项。纳入了 29 项病例研究/系列和 4 项队列/横断面研究。与因肝硬化导致的 PVT 相比,诊断时的年龄更低。在队列/横断面研究中,男性占 54.83%,而在病例报告/系列中,男性占 62.1%。肥胖、哮喘、高血压和糖尿病是最常见的合并症。大多数血栓形成事件发生在两周内。治疗旨在预防血栓进展和改善再通。根据证据,早期干预可预防肠缺血及其传播的不良预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a1/9650574/d69b2f655b3f/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a1/9650574/d69b2f655b3f/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a1/9650574/d69b2f655b3f/gr1_lrg.jpg

相似文献

1
Portal vein thrombosis in patients with COVID-19: A systematic review.新型冠状病毒肺炎患者门静脉血栓形成:系统评价。
Asian J Surg. 2023 Aug;46(8):3017-3026. doi: 10.1016/j.asjsur.2022.11.002. Epub 2022 Nov 11.
2
Anticoagulants for people hospitalised with COVID-19.COVID-19 住院患者的抗凝治疗。
Cochrane Database Syst Rev. 2022 Mar 4;3(3):CD013739. doi: 10.1002/14651858.CD013739.pub2.
3
Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies.抗血小板和抗凝药物用于抗磷脂抗体个体血栓形成的一级预防。
Cochrane Database Syst Rev. 2018 Jul 13;7(7):CD012534. doi: 10.1002/14651858.CD012534.pub2.
4
Epidemiology of portal vein thrombosis in liver cirrhosis: A systematic review and meta-analysis.肝硬化门静脉血栓形成的流行病学:系统评价和荟萃分析。
Eur J Intern Med. 2022 Oct;104:21-32. doi: 10.1016/j.ejim.2022.05.032. Epub 2022 Jun 7.
5
Home versus in-patient treatment for deep vein thrombosis.深静脉血栓形成的家庭治疗与住院治疗对比
Cochrane Database Syst Rev. 2018 Jan 9;1(1):CD003076. doi: 10.1002/14651858.CD003076.pub3.
6
Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.对有静脉血栓栓塞风险的住院患者实施血栓预防的干预措施。
Cochrane Database Syst Rev. 2018 Apr 24;4(4):CD008201. doi: 10.1002/14651858.CD008201.pub3.
7
Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies.门静脉血栓形成:诊断、治疗和未来临床研究的终点。
Lancet Gastroenterol Hepatol. 2024 Sep;9(9):859-883. doi: 10.1016/S2468-1253(24)00155-9. Epub 2024 Jul 9.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
The measurement and monitoring of surgical adverse events.手术不良事件的测量与监测
Health Technol Assess. 2001;5(22):1-194. doi: 10.3310/hta5220.
10
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.暴力死亡监测——2022年全国暴力死亡报告系统,50个州、哥伦比亚特区和波多黎各
MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1.

引用本文的文献

1
The Impact of COVID-19 and COVID-19 Vaccination on Detection, Assessment, and Management of Suspected Acute Drug-Induced Liver Injury Occurring during Clinical Trials: Consensus Recommendations from the IQ DILI Initiative.2019年冠状病毒病(COVID-19)及COVID-19疫苗接种对临床试验期间疑似急性药物性肝损伤的检测、评估及管理的影响:IQ药物性肝损伤倡议组织的共识建议
Drug Saf. 2025 Aug 5. doi: 10.1007/s40264-025-01591-0.
2
Etiology and Risk Factors for Splanchnic Vein Thrombosis in Non-Cirrhotic, Non-Neoplastic Patients: A Narrative Review.非肝硬化、非肿瘤患者内脏静脉血栓形成的病因及危险因素:一项叙述性综述
Medicina (Kaunas). 2025 May 21;61(5):933. doi: 10.3390/medicina61050933.
3
The Molecular Mechanisms of Portal Vein Thrombosis in Hepatocellular Carcinoma.
肝细胞癌门静脉血栓形成的分子机制
Cancers (Basel). 2024 Sep 24;16(19):3247. doi: 10.3390/cancers16193247.
4
Portal Vein Thrombosis in COVID-19: An Underdiagnosed Disease?新型冠状病毒肺炎中的门静脉血栓形成:一种诊断不足的疾病?
J Clin Med. 2024 Sep 21;13(18):5599. doi: 10.3390/jcm13185599.
5
Thrombotic Long-Term Consequences of SARS-CoV-2 Infection in Patients with Compensated Cirrhosis: A Propensity Score-Matched Analysis of a U.S. Database.代偿期肝硬化患者感染新型冠状病毒2的血栓形成长期后果:美国数据库的倾向评分匹配分析
Diseases. 2024 Jul 17;12(7):161. doi: 10.3390/diseases12070161.
6
Simultaneous portal vein thrombosis and splenic vein thrombosis in a COVID-19 patient: A case report and review of literature.一名新冠肺炎患者同时发生门静脉血栓形成和脾静脉血栓形成:病例报告及文献综述
World J Clin Cases. 2024 Jun 26;12(18):3561-3566. doi: 10.12998/wjcc.v12.i18.3561.
7
Portal Vein Thrombosis: State-of-the-Art Review.门静脉血栓形成:最新综述
J Clin Med. 2024 Mar 6;13(5):1517. doi: 10.3390/jcm13051517.
8
SARS-CoV-2 Infection Is an Independent Risk Factor for Decompensation in Cirrhosis Patients.新型冠状病毒2型感染是肝硬化患者失代偿的独立危险因素。
Diseases. 2024 Feb 25;12(3):46. doi: 10.3390/diseases12030046.
9
Septic Pylephlebitis in the Setting of COVID-19 Infection: A Case Report.COVID-19感染背景下的脓毒性门静脉炎:一例报告
Cureus. 2024 Jan 30;16(1):e53240. doi: 10.7759/cureus.53240. eCollection 2024 Jan.
10
Outcomes in Patients with Liver Dysfunction Post SARS-CoV-2 Infection: What Should We Measure?新型冠状病毒2型感染后肝功能不全患者的预后:我们应该测量什么?
Hepat Med. 2023 Oct 12;15:185-193. doi: 10.2147/HMER.S371507. eCollection 2023.